Inventor · disambiguated record
Chengzhang Shang
Also filed as: SHANG CHENGZHANG
8 granted patents·20 pending applications·9 citations·filing 2017–2024
77Inventor score
Files withBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD25BEIJING BIOCYTOGEN CO LTD1BIOCYTOGEN JIANGSU CO LTD1DOMA BIOPHARMACEUTICAL SUZHOU CO LTD1
Top patents by PatentIndex Score
28 records- 0191US10918095B2Genetically modified mice expressing humanized CD47BEIJING BIOCYTOGEN CO LTD·Filed 2019·Granted Feb 16, 2021·5 cites·15 claims
- 0288US10973212B2Genetically modified non-human animal with human or chimeric SIRPaBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Apr 13, 2021·4 cites·19 claims
- 0372US11723348B2Genetically modified mice expressing humanized CD47BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2020·Granted Aug 15, 2023·0 cites·13 claims
- 0471US2025122292A1Anti-egfr/met antibodies and uses thereofDOMA BIOPHARMACEUTICAL SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 0570US11071290B2Genetically modified non-human animal with human or chimeric CTLA-4BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Jul 27, 2021·0 cites·13 claims
- 0668US2025382373A1Anti-egfr/met antibodies and uses thereofBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 0767US11154041B2Genetically modified non-human animal with human or chimeric genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2020·Granted Oct 26, 2021·0 cites·17 claims
- 0865US10980222B2Genetically modified non-human animal with human or chimeric CD27BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Apr 20, 2021·0 cites·12 claims
- 0964US2022000086A1Genetically modified non-human animal with human or chimeric genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 1062US11096383B2Method of using a genetically modified mouse that expresses a humanized CTLA-4 geneBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2017·Granted Aug 24, 2021·0 cites·13 claims
- 1162US2025302016A1Genetically modified non-human animal with human or chimeric genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 1259US2025059297A1Anti-her2/trop2 antibodies and uses thereofBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 1359US2024268361A1Genetically modified non-human animal with human or chimeric tfr1BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 1455US2024081301A1Genetically modified non-human animal with human or chimeric fcrnBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 1555US2023172171A1Genetically modified non-human animal with human or chimeric cd94 and/or nkg2aBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 1655US2023227531A1Genetically modified non-human animal expressing a b2m/fcrn fusion proteinBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 1755US2024130340A1Genetically modified non-human animal with human or chimeric cd3 genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 1854US2023363362A1Genetically modified non-human animal with human or chimeric glp1rBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 1954US2023320332A1Genetically modified non-human animal with human or chimeric ccr8BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 2053US11350614B2Genetically modified non-human animal with human or chimeric CD28BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Jun 7, 2022·0 cites·15 claims
- 2153US2023058049A1GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPa/CD47BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2020·Application pending·0 cites
- 2253US2023072216A1Genetically modified non-human animal with human or chimeric mhc protein complexBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 2351US2021400933A1Genetically modified animal with canine or chimeric pd-1BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Application pending·0 cites
- 2451US2024224961A1Genetically modified non-human animal with human or chimeric il1rapBIOCYTOGEN JIANGSU CO LTD·Filed 2022·Application pending·0 cites
- 2550US2022312749A1Genetically modified non-human animal with human or chimeric il2raBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2020·Application pending·0 cites
- 2650US2022211019A1Genetically modified non-human animal with human or chimeric cd73BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Application pending·0 cites
- 2750US2022015343A1Genetically modified non-human animal with human or chimeric genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Application pending·0 cites
- 2850US2022272953A1Genetically modified non-human animal with human or chimeric il33BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chengzhang Shang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →